EUR 46.2
(2.21%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 27.14 Million | 14.3 Million | 6.02 Million | 4.22 Million | - |
Cost of Revenue | 25.72 Million | 13.32 Million | 4.91 Million | 3.12 Million | - |
Gross Profit | 1.41 Million | 980.1 Thousand | 1.1 Million | 1.1 Million | - |
Operating Expenses | 1.09 Million | 889.59 Thousand | 1.01 Million | 849.44 Thousand | - |
Selling, General and Administrative Expenses | - | - | - | - | - |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | 1.09 Million | - | - | - | - |
Cost and Expenses | 26.81 Million | 14.21 Million | 5.93 Million | 3.96 Million | - |
Operating Income | 327.63 Thousand | 90.51 Thousand | 90.62 Thousand | 258.86 Thousand | - |
Interest Expense | 25.77 Thousand | 14.59 Thousand | 153.31 Thousand | 63.66 Thousand | 80.41 Thousand |
Income Tax Expense | - | -67.8 Thousand | -112.84 Thousand | -672.00 | - |
Earnings before Tax | 322.37 Thousand | 146.03 Thousand | -48.18 Thousand | 195.3 Thousand | - |
Net Income | 320.22 Thousand | 203.77 Thousand | 64.65 Thousand | 175.58 Thousand | - |
Earnings Per Share Basic | 0.13 | 0.08 | 0.03 | 0.07 | 0.31 |
Earnings Per Share Diluted | 0.13 | 0.08 | 0.03 | 0.07 | 0.31 |
Weighted Average Shares Outstanding | 2.48 Million | 2.48 Million | 2.48 Million | 2.48 Million | 2.48 Million |
Weighted Average Shares Outstanding (Diluted) | 2.48 Million | 2.48 Million | 2.48 Million | 2.48 Million | 2.48 Million |
Gross Margin | 0.05 | 0.07 | 0.18 | 0.26 | - |
EBIT Margin | 0.03 | 0.02 | 0.02 | 0.06 | - |
Profit Margin | 0.01 | 0.01 | 0.01 | 0.04 | - |
EBITDA | 692.33 Thousand | 332.19 Thousand | 105.12 Thousand | 258.96 Thousand | 852.56 Thousand |
Earnings Before Tax Margin | 0.01 | 0.01 | 0.02 | 0.06 | - |
Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2019 FY |
---|---|---|---|---|---|
Revenue | 27.14 Million | 14.3 Million | 6.02 Million | 4.22 Million | - |
Cost of Revenue | 25.72 Million | 13.32 Million | 4.91 Million | 3.12 Million | - |
Gross Profit | 1.41 Million | 980.1 Thousand | 1.1 Million | 1.1 Million | - |
Operating Expenses | 1.09 Million | 889.59 Thousand | 1.01 Million | 849.44 Thousand | - |
Selling, General and Administrative Expenses | - | - | - | - | - |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | - | - | - | - | - |
Cost and Expenses | 26.81 Million | 14.21 Million | 5.93 Million | 3.96 Million | - |
Operating Income | 327.63 Thousand | 90.51 Thousand | 90.62 Thousand | 258.86 Thousand | - |
Interest Expense | 25.77 Thousand | 14.59 Thousand | 153.31 Thousand | 63.66 Thousand | - |
Income Tax Expense | 22.66 Thousand | -67.8 Thousand | -112.84 Thousand | -672.00 | - |
Earnings before Tax | 322.37 Thousand | 146.03 Thousand | -48.18 Thousand | 195.3 Thousand | - |
Net Income | 320.22 Thousand | 203.77 Thousand | 64.65 Thousand | 175.58 Thousand | - |
Earnings Per Share Basic | - | - | - | - | - |
Earnings Per Share Diluted | - | - | - | - | - |
Weighted Average Shares Outstanding | 2.48 Million | 2.48 Million | 2.48 Million | 2.48 Million | 2.48 Million |
Weighted Average Shares Outstanding (Diluted) | 2.48 Million | 2.48 Million | 2.48 Million | 2.48 Million | 2.48 Million |
Gross Margin | 0.05 | 0.07 | 0.18 | 0.26 | - |
EBIT Margin | - | - | - | - | - |
Profit Margin | 0.01 | 0.01 | 0.01 | 0.04 | - |
EBITDA | - | - | - | - | - |
Earnings Before Tax Margin | 0.01 | 0.01 | 0.02 | 0.06 | - |
688788
MEDICAMEQ
3880
8076
YIPS
STMEF